Hormonal Contraception And Antiretroviral Therapy Among Hiv-infected Women [contracepção Hormonal E Anti-retrovirais Em Mulheres Infectadas Pelo Hiv]

There is much controversy regarding the realtionship between the use of hormonal contraceptives and the risk of acquiring human immunodeficiency virus (HIV), and little is known about the effects of hormonal contraception in HIV-infected women (adverse events, menstrual disorders, disease progression, antiretroviral therapy interactions). The aim of the present study was to review available data regarding HIV vulnerability and transmission associated with hormonal contraceptives and the use of these contraceptives by women on antiretroviral therapy, with emphasis on drug interactions. In conclusion, it was not possible to offer evidence-based recommendations for the use of hormonal contraceptives among HIV-infected women under antiretroviral therapy. Infectious disease specialists and gynecologists providing care should be cautious about potential drug interaction leading to increase in adverse events, individualizing contraceptive drugs, route, and dosage, according to the antiretroviral therapy under use.2811680684Baeten, J.M., Lavreys, L., Sagar, M., Kreiss, J.K., Richardson, B.A., Chohan, B., Effect of contraceptive methods on natural history of HIV: Studies from the Mombasa cohort (2005) J Acquir Immune Defic Syndr, 38 (SUPPL. 1), pp. S18-S21Morrison, C.S., Richardson, B.A., Celentano, D.D., Chipato, T., Mmiro, F., Mugerwa, R., Prospective clinical trials designed to assess the use of hormonal contraceptives and risk of HIV acquisition (2005) J Acquir Immune Defic Syndr, 38 (SUPPL. 1), pp. S17-S18Allen, S., Why is fertility an issue for HIV-infected and at-risk women? (2005) J Acquir Immune Defic Syndr, 38 (SUPPL. 1), pp. S1-S3Mauck, C., Overview of why hormones may be an issue (2005) J Acquir Immune Defic Syndr, 38 (SUPPL. 1), pp. S11-S12Bahamondes, L., Trevisan, M., Andrade, L., Marchi, N.M., Castro, S., Díaz, J., The effect upon the human vaginal histology of the long-term use of the injectable contraceptive Depo-Provera® (2000) Contraception, 62 (1), pp. 23-27Martin Jr, H.L., Richardson, B.A., Mandaliya, K., Achola, J.O., Overbaugh, J., Kreiss, J.K., The early work on hormonal contraceptive use and HIV acquisition (2005) J Acquir Immune Defic Syndr, 38 (SUPPL. 1), pp. S12-S14Kiddugavu, M., Makumbi, F., Wawer, M.J., Serwadda, D., Sewankambo, N.K., Wabwire-Mangen, F., Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda (2003) AIDS, 17 (2), pp. 233-240Hormonal contraception and HIV: Science and Policy (2005) Africa Regional Meeting, , World Health Organization, Sep 19-21Nairobi, Africa;Robbins, G.K., De Gruttola, V., Shafer, R.W., Smeaton, L.M., Snyder, S.W., Pettinelli, C., Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection (2003) N Engl J Med, 349 (24), pp. 2293-2303Ministério da Saúde, (2006) Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV, , Brasília;Ministério da Saúde, (2006) Recomendações para profilaxia da transmissão vertical do HIV e terapia antiretroviral em gestantes, , Brasília;, 81pWeller, S., Davis, K., Condom effectiveness in reducing heterosexual HIV transmission Cochrane Database Syst Rev, 2005 (2). , CD003255(2004) Medical eligibility criteria for contraceptive use, , World Health Organization, 3rd ed. Geneva: WHO;Lavreys, L., Chohan, V., Overbaugh, J., Hassan, W., McClelland, R.S., Kreiss, J., Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women (2004) AIDS, 18 (16), pp. 2179-2184Chu, J.H., Gange, S.J., Anastos, K., Minkoff, H., Cejtin, H., Bacon, M., Hormonal contraceptive use and the effectiveness of highly active antiretroviral therapy (2005) Am J Epidemiol, 161 (9), pp. 881-890Clark, R.A., Theall, K.P., Trends and correlates of hormonal contraception use among HIV-infected women (2004) J Acquir Immune Defic Syndr, 36 (4), pp. 986-988Heikinheimo, O., Lehtovirta, P., Suni, J., Paavonen, J., The levonorgestrel- releasing intrauterine system (LNG-IUS) in HIV-infected women - effects on bleeding patterns, ovarian function and genital shedding of HIV (2006) Hum Reprod, 21 (11), pp. 2857-2861Nies AS, Spielberg SP. Princípios da terapêutica. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG. Goodman &ampGilman as bases farmacológicas da terapêutica. 9a ed. New York: McGraw-Hill1996. p. 31-44Benet LZ, Kroetz DL, Sheiner LB. Farmacocinética A dinâmica da absorção, distribuição e eliminação dos fármacos. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG. Goodman &ampGilman as bases farmacológicas da terapêutica. 9a ed. New York: McGraw-Hill1996. p. 3-20Smith, P.F., DiCenzo, R., Morse, G.D., Clinical pharmacokinetics of non-nucleoside reverse transcriptase inhibitors (2001) Clin Pharmacokinet, 40 (12), pp. 893-905Nebert, D.W., Russell, D.W., Clinical importance of the cytochromes P450 (2002) Lancet, 360 (9340), pp. 1155-1162Kobayashi, K., Mimura, N., Fujii, H., Minami, H., Sasaki, Y., Shimada, N., Role of human cytochrome P450 3A4 in metabolism of medroxyprogesterone acetate (2000) Clin Cancer Res, 6 (8), pp. 3297-3303Ouellet, D., Hsu, A., Qian, J., Locke, C.S., Eason, C.J., Cavanaugh, J.H., Effect of ritonavir on the pharmacokinetics of ethinyl oestradiol in healthy female volunteers (1998) Br J Clin Pharmacol, 46 (2), pp. 111-116Mildvan, D., Yarrish, R., Marshak, A., Hutman, H.W., McDonough, M., Lamson, M., Pharmacokinetic interaction between nevirapine and ethinyl estradiol/ norethindrone when administered concurrently to HIV-infected women (2002) J Acquir Immune Defic Syndr, 29 (5), pp. 471-477Heard, I., Data from the French cohort studies and framing the French contraceptive guidelines (2005) J Acquir Immune Defic Syndr, 38 (SUPPL. 1), pp. S29-S31Fröhlich, M., Burhenne, J., Martin-Facklam, M., Weiss, J., von Wolff, M., Strowitzki, T., Oral contraception does not alter single dose saquinavir phamacokinetics in women (2004) Br J Clin Pharmacol, 57 (3), pp. 244-252Catanzaro, L.M., Morse, G.D., Data from clinical trials (2005) J Acquir Immune Defic Syndr, 38 (SUPPL. 1), pp. S26-S2